Genprex (GNPX) Current Assets (2016 - 2026)
Genprex (GNPX) posted quarterly Current Assets of $18.8 million for Q1 2026, up 351.59% year-over-year from $4.2 million in Q1 2025, and up 125.0% quarter-over-quarter from $8.4 million in Q4 2025.
Genprex (GNPX) Current Assets (2016 - 2026) Analysis & Trends
Genprex's Current Assets history runs 11 years deep, the most recent figure standing at $18.8 million for Q1 2026.
- In Q1 2026, Current Assets rose 351.59% year-over-year to $18.8 million; the TTM figure through Mar 2026 stood at $18.8 million (up 351.59% YoY), while the FY2025 annual figure was $8.4 million, up 302.26% from the prior year.
- Current Assets for Q1 2026 stood at $18.8 million, up from $8.4 million in the prior quarter.
- The five-year high for Current Assets was $35.7 million in Q1 2022, with the low at $1.7 million in Q3 2025.
- The 5-year median for Current Assets is $9.2 million (2024), against an average of $12.9 million.
- The sharpest annual moves came in 2024 and 2026: Current Assets slumped 85.09% in 2024, then soared 351.59% in 2026.
- Genprex's Current Assets stood at $21.5 million in 2022, then sank by 64.92% to $7.5 million in 2023, then tumbled by 72.42% to $2.1 million in 2024, then jumped by 302.26% to $8.4 million in 2025, then jumped by 125.0% to $18.8 million in 2026.
- Business Quant data shows GNPX's Current Assets at $18.8 million in Q1 2026, $8.4 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - | 15.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.80 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 4.39 Mn |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 7.53 Mn |
| Sep 30, 2023 | 12.86 Mn |
| Jun 30, 2023 | 12.37 Mn |
| Mar 31, 2023 | 19.94 Mn |
| Dec 31, 2022 | 21.47 Mn |
| Sep 30, 2022 | 26.31 Mn |
| Jun 30, 2022 | 30.90 Mn |
| Mar 31, 2022 | 35.70 Mn |
| Dec 31, 2021 | 39.14 Mn |
| Sep 30, 2021 | 45.64 Mn |
| Jun 30, 2021 | 48.06 Mn |